By Richa Naidu VEVEY, Switzerland, August 17 (Reuters) – Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Reports: Pitt QB Mason Heintschel (knee) done for season
Pitt quarterback Mason Heintschel will reportedly miss the rest of the season with a torn…
Solberg takes Sardinia lead to keep WRC title hopes alive
VIDEO SHOWS: HIGHLIGHTS OF THE EARLY STAGES OF DAY 3 OF RALLY ITALY COMPLETE SCRIPT…
Top 25 roundup: CJ Carr's 5-TD day leads No. 3 Notre Dame over UNC
CJ Carr threw for four touchdowns and ran for another as No. 3 Notre Dame…
